Asia-Pacific Presbyopia Treatment Market to Grow by a CAGR of 8.51% during 2020-2028
Research Nester has released a report titled “Asia Pacific Presbyopia Treatment Market - Demand Analysis & Opportunity Outlook 2028” which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness, year-on-year (Y-O-Y) growth comparisons, market share comparisons, BPS analysis, SWOT analysis and Porter’s five force model.
The Asia Pacific presbyopia treatment market has shown significant growth on account of increasing geriatric population and growing prevalence of presbyopia across the Asia Pacific region. The Asia Pacific presbyopia treatment market accounted for a market value of USD 1760.0 million in 2019 and is anticipated to reach USD 3658.05 million by 2028, by growing at a CAGR of 8.51% during the forecast period i.e. 2020-2028. The increased demand for innovative products from China, Japan & India, is one of the primary factors driving the region's market growth. Non‑invasive methods of treating presbyopia have been used for many years in this region. On the other hand, bifocal or multifocal progressive addition lenses also provide satisfactory and acceptable near vision without the possible risks of a surgical technique, which is further driving the growth of the Asia Pacific presbyopia treatment market.
“The Final Report will cover the impact analysis of COVID-19 on this industry.”
Download/Request Sample Copy of Strategic Report: https://www.researchnester.com/sample-request-2824
The presbyopia treatment market is segmented based on treatment type into corrective eyeglasses, contact lenses, refractive surgery, lens implants, and pharmacological treatment. Among them, corrective eyeglasses accounted for the largest market share in 2019. Now-a-days, people prefer to wear contact lenses rather than eyeglasses. There are currently various types of contact lenses available in the market, including bifocal lenses, monovision lenses, and modified monovision. The most common type of refractive surgery currently being performed is laser-assisted in situ keratomileusis (LASIK), the treatment is associated with significantly less pain, thus encouraging numerous patients to obtain the proper treatment.
Increasing Geriatric Population And Growing Prevalence of Presbyopia Across the Asia Pacific Region To Propel the Market Growth
One of the most prominent vision disorders requiring specialist ophthalmic diagnosis and treatment is presbyopia. The occurrence rate of Presbyopia is increasing across the Asia Pacific region owing to unhealthy lifestyles and other causes, such as environmental changes. In the ageing population or in people over 40 years of age, the incidence of vision-related disorders is very high. The increasing number of older people living with presbyopia is a major factor that is expected to drive the growth of the presbyopia treatment market in all Asia Pacific countries.
Download Sample of This Strategic Report: https://www.researchnester.com/sample-request-2824
However, rising healthcare cost on account of using high quality imported equipment to meet the clinical demands of ophthalmology, lack of sufficient health care personnel to treat presbyopia and funding support for the treatment, are estimated to act as barriers to the growth of the Asia Pacific presbyopia treatment market during the forecast period.
This report also provides the existing competitive scenario of some of the key players of the presbyopia treatment market which includes company profiling of NIDEK CO., LTD, Johnson & Johnson Vision Care, Inc., Alcon Vision LLC, Carl Zeiss AG, Bausch & Lomb Incorporated, Essilor International, Ziemer Ophthalmic Systems AG, Topcon Corporation (TYO: 7732), Novartis AG (SWX: NOVN) and others.
The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. Conclusively, the report titled “Asia Pacific Presbyopia Treatment Market – Demand Analysis & Opportunity Outlook 2028”, analyses the overall presbyopia treatment industry to help new entrants to understand the details of the market. In addition to that, this report also guides existing players looking for expansion and major investors looking for investment in the Asia Pacific presbyopia treatment market in the near future.
Contact for more Info:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919